Skip to content
value.today

Amphastar Pharmaceuticals, Inc. vs Solid Biosciences Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Amphastar Pharmaceuticals, Inc. is the larger company by market value: $1.1 B against $713 M for Solid Biosciences Inc., 1.5 times as much (market caps of Oct 28, 2026 for Amphastar Pharmaceuticals, Inc. and Oct 30, 2026 for Solid Biosciences Inc.).
  • Amphastar Pharmaceuticals, Inc. made a net profit of $98 M, while Solid Biosciences Inc. made a net loss of $174 M.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

01232473704932020202120222023202420252026Amphastar Pharmaceuticals, Inc. 121Solid Biosciences Inc. 357

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$1B$1B201720182019202020212022202320242025Amphastar Pharmaceuticals, Inc. $1BSolid Biosciences Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAmphastar Pharmaceuticals, Inc.
AMPH · #8,923 in the world
Solid Biosciences Inc.
SLDB · #11,013 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded—2013
Size
Market cap$1.1 B$713 M
Revenue$720 M—
Net income$98 M▲ best$-174 M
Employees1,761—
Valuation
P/E ratio11.0×—
Price to sales1.5×—
Price to book1.4×4.0×
Free cash flow yield11.1%▲ best-22.1%
Profitability
Gross margin49.5%—
Operating margin19.5%—
Net margin13.6%—
Return on equity12.9%▲ best-109.9%
Return on invested capital9.2%—
Growth
Revenue growth-1.6%—
Revenue growth, 3 years a year13.0%—
Earnings per share growth-33.7%—
Financial strength
Debt to equity0.8×—
Cash
Free cash flow margin16.8%—
Shareholder returns
Shareholder yield6.9%—
Strength scores
Piotroski F-score6 of 9—
Altman Z-score zonegrey—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Amphastar Pharmaceuticals, Inc. or Solid Biosciences Inc.?

Amphastar Pharmaceuticals, Inc. is the larger company by market value: $1.1 B against $713 M for Solid Biosciences Inc., 1.5 times as much (market caps of Oct 28, 2026 for Amphastar Pharmaceuticals, Inc. and Oct 30, 2026 for Solid Biosciences Inc.).

Which makes more money, Amphastar Pharmaceuticals, Inc. or Solid Biosciences Inc.?

Amphastar Pharmaceuticals, Inc. made a net profit of $98 M, while Solid Biosciences Inc. made a net loss of $174 M.

Sources#

Every figure on this page comes from these, with the date shown next to it.